Celine Christine Martin

CIK: 0002092680

Transaction Breakdown

Open Market Buys (P)1 (20.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

FUL

FULLER H B CO

Director

CNMD

CONMED Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

FUL
FULLER H B CO
Sep 30, 2026
Purchase(P)
Direct
465 shares at avg. $49.50$23K
FUL
FULLER H B CO
Jul 15, 2026
Award(A)
Stock Units
Direct
2.9K shares at avg. $57.00-
CNMD
CONMED Corp
Jul 1, 2026
Award(A)
RSUs (Restricted Stock Units)
Direct
5.6K shares-
FUL
FULLER H B CO
Jan 26, 2026
Award(A)
Restricted Stock Units
Direct
1.3K shares-
FUL
FULLER H B CO
Jan 26, 2026
Award(A)
Restricted Stock Units
Direct
1.3K shares-

		Type	Shares	Price		Ownership
Sep 30, 2026	FUL FULLER H B CO	Purchase(P)	465	$49.50	$22,998	Direct
Jul 15, 2026	FUL FULLER H B CO	Award(A) Stock Units	2,895	$57.00	-	Direct
Jul 1, 2026	CNMD CONMED Corp	Award(A) RSUs (Restricted Stock Units)	5,603	-	-	Direct
Jan 26, 2026	FUL FULLER H B CO	Award(A) Restricted Stock Units	1,300	-	-	Direct
Jan 26, 2026	FUL FULLER H B CO	Award(A) Restricted Stock Units	1,300	-	-	Direct

1-5 of 5 transactions

About Martin Celine Christine

Martin Celine Christine (SEC CIK 0002092680) files insider reports with the SEC as Director of FULLER H B CO (FUL) and Director of CONMED Corp (CNMD).

Signal8 holds 7 ownership filings by Martin Celine Christine (2 Form 3, 5 Form 4), filed between Dec 1, 2025 and Oct 1, 2026. Those filings report 5 transactions, from Jan 26, 2026 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Martin Celine Christine's filings is in ST. PAUL, MN.

Recent filings by Martin Celine Christine

Sep 30, 2026: Open-market purchase of FUL shares (Form 4, code P).
Jul 15, 2026: Grant or award of FUL derivative securities (Form 4, code A).
Jul 1, 2026: Grant or award of CNMD derivative securities (Form 4, code A).
Jan 26, 2026: Grants or awards of FUL derivative securities (2 lines, Form 4, code A).

Other insiders filing for FULLER H B CO (FUL)

Corkrean John J, Executive VP and CFO
Campe Heather, Sr. VP, International Growth
Malik Muhammad Shahbaz, Senior VP, BAS
BAILLY R JEFFREY, Director
Ogunsanya Gregory O., Sr. VP, GC and Corp Secretary
Happe Michael J, Director

How to read Form 4 transaction codes